Skip to main content

Table 1 Baseline and perioperative characteristics of parturients

From: The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial

 

Group B (n = 100)

Group FB (n = 100)

Group DB (n = 100)

P-Value

Age (yr.)

27 (26–29)

27 (25–30)

27 (25–29)

0.244

Height (cm)

161.5 (159.0–164.0)

162.0 (159.0–165.0)

160 (159.0–164.0)

0.284

Weight (kg)

72.3 ± 6.2

72.8 ± 5.3

72.6 ± 5.3

0.771

BMI (kg/m2)

27.6 ± 2.5

27.6 ± 2.2

27.8 ± 2.3

0.865

ASA physical status, n (%)

   

0.394

 II

78 (78)

74 (74)

82 (82)

 III

22 (22)

26 (26)

18 (18)

Gestational week (Wk.)

39 (38–39)

39 (38–39)

39 (38–39)

0.379

Peak sensory level

   

0.846

 T2

2 (2)

1 (1)

1 (1)

 T4

37 (37)

36 (36)

42 (42)

 T6

61 (61)

63 (63)

57 (57)

Surgery duration (min)

41.0 (38.0–44.0)

41.0 (39.0–44.0)

41.0 (39.0–44.0)

0.746

Intraoperative fluid volume (ml)

1351.1 ± 115.4

1361.6 ± 97.8

1356.5 ± 98.7

0.775

Intraoperative blood loss (ml)

421.2 ± 36.0

424.5 ± 30.5

423.1 ± 30.7

0.773

  1. Notes: Data are presented as n (%) or mean ± SD or median (range); There were no significant differences among the three groups (P > 0.05). Group B = bupivacaine group; Group FB = bupivacaine and fentanyl group; Group DB = bupivacaine and dexmedetomidine group
  2. Abbreviations: ASA American Society of Anesthesiologists, BMI Body Mass Index